Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas

Supportive Care in Cancer

Volumn 20, Issue 9, 2012, Pages 2053-2059

  Nishimura, Noriko ^a   Nakano, Kenji ^a   Ueda, Kyoko ^a   Kodaira, Makoto ^a   Yamada, Shuhei ^a   Mishima, Yuko ^a   Yokoyama, Masahiro ^a   Terui, Yasuhito ^a   Takahashi, Shunji ^a   Hatake, Kiyohiko ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Chemotherapy; Incidence; Oral mucositis; Severity

Indexed keywords

AZULENE DERIVATIVE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MOUTHWASH; OXALIPLATIN; PACLITAXEL; PREDNISONE; RITUXIMAB; SODIUM AZULENE SULFONATE; UNCLASSIFIED DRUG; VINCRISTINE SULFATE;

ADULT; AGED; ANOREXIA; BREAST CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER OF UNKNOWN PRIMARY SITE; COLORECTAL CANCER; CONTINUOUS INFUSION; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DYSPHAGIA; ESOPHAGUS CANCER; EVALUATION; FEMALE; GASTROINTESTINAL SYMPTOM; HEAD AND NECK CANCER; HUMAN; INCIDENCE; LABORATORY TEST; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MOUTH HYGIENE; ORAL MUCOSITIS; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SOLID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STOMATITIS; YOUNG ADULT;

EID: 84865195671     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-011-1314-6     Document Type: Review

References (12)

1. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531-1539 (Pubitemid 37151510)
2. Garden AS, Chambers MS (2007) Head and neck radiation and mucositis. Curr Opin Support Palliat Care 1:30-34
3. Jones JA, Avritscher EB, Cooksley CD, Michelet M, Bekele BN, Elting LS (2006) Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Supportive Care Cancer 14:505-515
4. Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820-831 (Pubitemid 46335677)
5. Leborgne JH, Leborgne F, Zubizarreta E, Ortega B, Mezzera J (1998) Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomized trial. Radiother Oncol 47:145-148 (Pubitemid 28275923)
6. Peterson DE, Bensadoun RJ, Roila F (2008) Management of oral and gastrointestinal mucositis: ESMO clinical recommendations. Ann Oncol 19(2):122-125
7. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100:2026-2046 (Pubitemid 38525884)
8. Ruescher T, Sodeifi A, Scrivani S, Kaban L, Sonis S (1998) The impact of mucositis of alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 82:2275-2281 (Pubitemid 28240837)
9. Sonis S, Oster G, Fuchs HJ (2001) Oral mucositis and the clinical and economic outocomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201-2205 (Pubitemid 32372323)
10. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995-2025 (Pubitemid 38528741)
11. Spielberger R, Stiff P, Gensinger W, Gentile T, Emmanouilides C (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Eng J Med 351:2590-2598 (Pubitemid 39628580)
12. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253-262 (Pubitemid 36556043)